Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan

Journal of Urology

Volumn 159, Issue 6, 1998, Pages 2215-2219

  Tanaka, Masatoshi ^a   Takahashi, Koichi ^b   Saika, Takeshi ^b   Kobayashi, Intetsu ^b   Ueno, Takamasa ^b   Kumazawa, Joichi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

Fluoroquinolone; Mutations in GyrA and Parc proteins; Neisseria gonorrhoeae; Resistance

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; NORFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; SPARFLOXACIN; SPECTINOMYCIN; TETRACYCLINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032412927     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63308-1     Document Type: Article

References (22)

1. Covino, J. M., Cummings, M., Smith, B., Benes, S., Draft, K. and McCormack, W. M.: Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillin-producing and non-penicillin-producing strains. Antimicrob. Agents Chemother., 34: 148, 1990.
2. Bryan, J. P., Hira, S. K., Brady, W., Luo, N., Mwale, C., Mpoko, G., Krieg, R., Siwiwaliondo, E., Reichart, C., Waters, C. and Perine, P.: Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia. Antimicrob. Agents Chemother., 34: 819, 1990.
3. Tanaka, M., Matsumoto, T., Kumazawa, J. and Nagayama, A.: Sparfloxacin in the treatment of males with urethritis. Eur. J. Clin. Microbiol. Infect. Dis., 11: 660, 1992.
4. Gransden, W. R., Warren, C. A., Phillips, I., Hodges, M. and Barlow, D.: Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet, 335: 51, 1990.
5. Jephcott, A. E. and Turner, A.: Ciprofloxacin resistance in gonococci. Lancet, 335: 165, 1990.
6. Clendennen, III T. E., Hames, C. S., Kees, E. S., Price, F. C., Rueppel, W. J., Andrada, A. B., Espinosa, G. E., Kabrerra, G. and Wignall, F. S.: In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines. Antimicrob. Agents Chemother., 36: 277, 1992.
7. Bogaerts, J., Tello, W. M., Akingeneye, J., Mukantabana, V., Van Dyck, E. and Piot, P.: Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda. Genitourin. Med., 69: 196, 1993.
8. Knapp, J. S., Washington, J. A., Doyle, L. J., Neal, S. W., Parekh, M. C. and Rice, R. J.: Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993. Antimicrob. Agents Chemother., 38: 2194, 1994.
9. Knapp, J. S., Ohye, R., Neal, S. W., Parekh, M. C., Higa, H. and Rice, R. J.: Emerging in vitro resistance to quinolones in penicillinase- producing Neisseria gonorrhoeae strains in Hawaii. Antimicrob. Agents Chemother., 38: 2200, 1994.
10. Tapsall, J. W., Shultz, T. R. and Phillips, E. A.: Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to quinolone antibiotics. Pathology, 24: 27, 1992.
11. Kam, K. M., Lo, K. K., Ho, Ng. K. and Cheung, M. M.: Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance. Genitourin. Med., 71: 141, 1995.
12. Tanaka, M., Kumazawa, J., Matsumoto, T. and Kobayashi, I.: High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan. Genitourin. Med., 70: 90, 1994.
13. Tanaka, M., Matsumoto, T., Kobayashi, I., Uchino, U. and Kumazawa, J.: Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan. Antimicrob. Agents Chemother., 39: 2367, 1995.
14. Belland, R. J., Morrison, S. G., Ison, C. and Huang, W. M.: Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone resistant isolates. Mol. Microbiol., 14: 371, 1994.
15. Tanaka, M., Otsuki, M., Nishino, T., Kobayashi, I., Matsumoto, T. and Kumazawa, J.: Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae. Genitourin. Med., 72: 295, 1996.
16. National Committee for Clinical Laboratory Standards.: Approved standard M2-A3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1993.
17. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A. and Struhl, K.: Current Protocols in Molecular Biology. New York: Greene Publishing and Wiley-Interscience. 1989.
18. Messing, J.: New M13 vectors for cloning. Methods Enzymol., 101: 20, 1983.
19. Knapp, J. S., Fox, K. K., Trees, D. L. and Whittington, W. L.: Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg. Infect. Dis., 3: 33, 1997.
20. Corkill, J. E., Percival, A. and Lind, M.: Reduced uptake of ciprofloxacin in a resistant of Neisseria gonorrhoeae and transformation of resistance to other strains. J. Antimicrob. Chemother., 28: 601, 1983.
21. Tapsall, J. W., Shultz, T. R., Lovett, R. and Munro, R.: Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea. Med. J. Aust., 156: 143, 1992.
22. Tapsall, J. W., Limnios, E. A., Thacker, C., Donovan, B., Lynch, S. D., Kirby, L. J., Wise, K. A. and Carmody, C. J.: High-level quinolone resistance in Neisseria gonorrhoeae: a report of two cases. Sex. Transm. Dis., 22: 310, 1995.